Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model.
Using an animal model, we have previously shown that preeclampsia results in long-term adverse neuromotor outcomes in the offspring, and this phenotype was prevented by antenatal treatment with pravastatin. This study aims to localize the altered neuromotor programming in this animal model and to ev...
Main Authors: | Alissa R Carver, Maria Andrikopoulou, Jun Lei, Esther Tamayo, Phyllis Gamble, Zhipeng Hou, Jiangyang Zhang, Susumu Mori, George R Saade, Maged M Costantine, Irina Burd |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4071009?pdf=render |
Similar Items
-
Pravastatin induces NO synthesis by enhancing microsomal arginine uptake in healthy and preeclamptic placentas
by: Zita Pánczél, et al.
Published: (2019-11-01) -
Is There a Causal Relation between Maternal Acetaminophen Administration and ADHD?
by: Antonio Saad, et al.
Published: (2016-01-01) -
Maternal-Fetal HLA Compatibility in Uncomplicated and Preeclamptic Naturally Conceived Pregnancies
by: Liseanne J. van ‘t Hof, et al.
Published: (2021-05-01) -
Maternal Low Volume Circulation Relates to Normotensive and Preeclamptic Fetal Growth Restriction
by: Wilfried Gyselaers, et al.
Published: (2022-06-01) -
Evaluation of fetal stress in preeclamptic patients
by: Can, Esra, et al.
Published: (2020-04-01)